Session 284: Antivirals and Use of PCR Testing for Respiratory Viruses
The IDWeek 2019 Digital Library is intended as a resource to view IDWeek sessions virtually and claim CME credit. If you plan to claim CME credit for a session, please ensure you have first watched the session video in the DIGITAL LIBRARY prior to completing the evaluation form.
Faculty and Disclosures
Susan Gerber, MD; Chief, Respiratory Viruses Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, COI Disclosures: Nothing to disclose
Inger Damon, MD, PhD; Director Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, COI Disclosures: Nothing to disclose
Richard Hodinka PhD; Professor, Microbiology; Chair, Department of Biomedical Sciences, University of South Carolina, COI Disclosures: Nothing to disclose
Evan Anderson, MD; Infectious Diseases Physician, Emory University, Atlanta VA Medical Center, COI Disclosures: "AbbVie: Consultant, MedImmune: Scientific Research Study Investigator, Merck: Scientific Research Study Investigator, Micron Biomedical: Scientific Research Study Investigator, Novavax: Grant/Research Support, PaxVax: Scientific Research Study Investigatorm, Pfizer: Consultant, Grant/Research Support, Regeneron: Scientific Research Study Investigator, Sanofi Pasteur: Scientific Research Study Investigator"
Flor Munoz, MD; Associate Professor of Pediatrics, Baylor College of Medicine, COI Disclosures: "Biocryst: Grant/Research Support CDC: Research Grant, Moderna: Other Financial or Material Support, Safety Monitoring Board Member/Chair, NIH: Research Grant, Novavax: Research Grant, UP to Date: Author and Editor - Royalties, Other Financial or Material Support"
IDSA is accredited by the Accreditation Council for Continuing Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
IDSA designates this enduring material for a maximum of 25.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.25 AMA PRA Category 1 Credit(s)™